Intech Biopharm Corporation
Research Intech Biopharm Corporation (6461.TWO) on Bullrun: market cap TWD 1.97B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6461.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyTWD
- Market capTWD 1.97B
- Financial periodQ2 2026
- RevenueTWD 18.83M
- Net income-TWD 102.71M
- Free cash flow-TWD 99.44M
- Gross margin-251.9%
Valuation Snapshot
latest market cap is TWD 1.97B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 1.97B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 TWD.
About Intech Biopharm Corporation
Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. The company offers combinations, formulations, and generic drugs for the treatment of respiratory diseases using technology platforms, such as inhaled low ethanol formulation, a metered dose inhaler platform for treating asthma and COPD, as well as dry powder inhaler that comprises blisters and capsules.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Intech Biopharm Corporation's market cap?
Intech Biopharm Corporation's market capitalization is TWD 1.97B.
What does Intech Biopharm Corporation do?
Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. The company offers combinations, formulations, and generic drugs for the treatment of respiratory diseases using technology platforms, such as inhaled low ethanol formulation, a metered dose inhaler platform for treating asthma and COPD, as well as dry powder inhaler that comprises blisters and capsules. Its products include SYN006, SYN010, SYN007, Synflutide, Duasma,Synvent, and SYN011.